CFO
INGR icon

Callan Family Office’s Ingredion INGR Stock Holding History

Callan Family Office’s Portfolio INGR Stock Details INGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$246K Buy
+2,598
New +$275K ﹤0.01% 1070

Other funds holding INGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
YAM
Yacktman Asset Management Austin, Texas $8.09B AUM 19.03% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Callan Family Office's INGR Position: Q2 2026 in Review

Callan Family Office opened a new position in Ingredion (INGR) in Q2 2026: 2,598 shares worth $246K. The stake represents ﹤0.01% of the portfolio and ranks #1070 among its holdings.

609 funds tracked by Wall St. Rank hold INGR as of Q2 2026.

  • Callan Family Office held 2,598 shares of Ingredion worth $246K as of Q2 2026.
  • Ingredion was a new Callan Family Office position in Q2 2026.
  • Ingredion made up ﹤0.01% of Callan Family Office's portfolio in Q2 2026, its #1070 holding.
  • 609 funds tracked by Wall St. Rank held Ingredion as of Q2 2026.

Based on Callan Family Office's 13F filing for Q2 2026, filed 11 Aug 2026.